|
EORTC1527/JCOG1609INT: Diffusion-weighted MRI (DW-MRI) assessment of liver metastasis to improve surgical planning (DREAM). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Eisai; Merck Serono; Nihonkayaku; Taiho Pharmaceutical |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Otsuka |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck; Novartis; Roche; Sanofi; SERVIER; Sirtex Medical |
Speakers' Bureau - Lilly; Merck Serono; Novartis; Roche; Sanofi; TERUMO |
Research Funding - Merck Serono (Inst); Pfizer (Inst); Roche (Inst) |
|
|
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical |
Research Funding - Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Taiho Pharmaceutical (Inst) |
|
|
Honoraria - Merck Serono; Regeneron |
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Merck Serono; Regeneron; Roche/Genentech |
Speakers' Bureau - Merck Serono; Roche; Sanofi |
Research Funding - Merck Serono (Inst); Regeneron (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |